Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.256NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Q.7 (Alpha)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Q.7 (Alpha)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Q.7 (Alpha)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Q.7 (Alpha)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.460ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.460ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.460ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.460NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.262ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.262ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.262ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.262NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.9ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.9NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBUORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBUENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBUENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBUNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.351.5 (Beta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.351.5 (Beta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.351.5 (Beta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.351.5 (Beta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FZ.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FZ.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FZ.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FZ.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.9.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.9.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.9.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.9.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBC.1.6.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBC.1.6.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBC.1.6.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBC.1.6.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.4.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.4.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.4.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.4.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FQ.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FQ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FQ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FQ.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JB.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JB.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JB.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JB.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.17ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used